<span item_type="fundamental" item_id="fb8fc2bbb8b51307755c0d4405a8daf2" counter_id="ST/US/APYP" env="prod"></span><span item_type="announcement" item_id="550905531665551361" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 1 K.</p><p>EPS: As of FY2025 Q2, the actual value is USD 0.</p><p></p><h3>Segment Revenue</h3><ul><li>Revenues for the three months ended June 30, 2025, were $1,000, compared to $2,000 for the same period in 2024. For the six months ended June 30, 2025, revenues were $4,000, compared to $15,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Gross profit (loss) for the three months ended June 30, 2025, was -$3,000, compared to -$1,000 in 2024. For the six months ended June 30, 2025, gross profit (loss) was -$4,000, compared to $9,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>Operating loss for the three months ended June 30, 2025, was -$353,000, compared to -$405,000 in 2024. For the six months ended June 30, 2025, operating loss was -$476,000, compared to -$803,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>Net profit (loss) for the three months ended June 30, 2025, was -$6,000, compared to $181,000 in 2024. For the six months ended June 30, 2025, net loss was -$172,000, compared to -$1,063,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities for the six months ended June 30, 2025, was $213,000, compared to $442,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>Net cash used in investing activities for the six months ended June 30, 2025, was $1,000, compared to $78,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>Net cash provided by financing activities for the six months ended June 30, 2025, was -$124,000, compared to -$456,000 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li>The company plans to file a 510(k) FDA submission for the AppySleep LAB app for the non-contact diagnosis of sleep apnea during 2026, and an FDA process for AppySleep PRO for the treatment of sleep apnea during 2027.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>The company aims to establish its technology and related products as the gold standard for the targeted sectors over the next five years, focusing on developing a balanced and diverse pipeline of products and product candidates.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li><li>The company intends to maintain a global, diverse network of specialists to accelerate knowledge synergies and innovation, and establish distribution channels to maximize the commercial potential of its products.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1568969/000164117225024651/form10-q.htm"></span></li></ul>

AppYea, Inc. | 10-Q: FY2025 Q2 Revenue: USD 1 K